- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Palbociclib – March 2018
Palbociclib: Capsules, 75 mg, 100 mg, 125 mg; Ibrance®
Last updated
29 June 2018